319 related articles for article (PubMed ID: 31931100)
1. Immunotherapy in sepsis - brake or accelerate?
Steinhagen F; Schmidt SV; Schewe JC; Peukert K; Klinman DM; Bode C
Pharmacol Ther; 2020 Apr; 208():107476. PubMed ID: 31931100
[TBL] [Abstract][Full Text] [Related]
2. Sepsis Care Pathway 2019.
Labib A
Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
[No Abstract] [Full Text] [Related]
3. Immunotherapy of Sepsis: Blind Alley or Call for Personalized Assessment?
Prucha M; Zazula R; Russwurm S
Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):37-49. PubMed ID: 27554587
[TBL] [Abstract][Full Text] [Related]
4. Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trial.
Kalvelage C; Zacharowski K; Bauhofer A; Gockel U; Adamzik M; Nierhaus A; Kujath P; Eckmann C; Pletz MW; Bracht H; Simon TP; Winkler M; Kindgen-Milles D; Albertsmeier M; Weigand M; Ellger B; Ragaller M; Ullrich R; Marx G
Trials; 2019 Mar; 20(1):156. PubMed ID: 30832742
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory therapies in sepsis.
Kox WJ; Volk T; Kox SN; Volk HD
Intensive Care Med; 2000; 26 Suppl 1():S124-8. PubMed ID: 10786969
[TBL] [Abstract][Full Text] [Related]
6. Precision Immunotherapy for Sepsis.
Peters van Ton AM; Kox M; Abdo WF; Pickkers P
Front Immunol; 2018; 9():1926. PubMed ID: 30233566
[TBL] [Abstract][Full Text] [Related]
7. Targeting the host response in sepsis: current approaches and future evidence.
Bode C; Weis S; Sauer A; Wendel-Garcia P; David S
Crit Care; 2023 Dec; 27(1):478. PubMed ID: 38057824
[TBL] [Abstract][Full Text] [Related]
8. Staging and Personalized Intervention for Infection and Sepsis.
Beckmann N; Salyer CE; Crisologo PA; Nomellini V; Caldwell CC
Surg Infect (Larchmt); 2020 Nov; 21(9):732-744. PubMed ID: 32240042
[No Abstract] [Full Text] [Related]
9. [Immunomodulation for sepsis: a change of tack?].
Leentjens J; Kox M; Pickkers P
Ned Tijdschr Geneeskd; 2014; 158():A6859. PubMed ID: 24518844
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
Patil NK; Bohannon JK; Sherwood ER
Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
[TBL] [Abstract][Full Text] [Related]
11. The immune system's role in sepsis progression, resolution, and long-term outcome.
Delano MJ; Ward PA
Immunol Rev; 2016 Nov; 274(1):330-353. PubMed ID: 27782333
[TBL] [Abstract][Full Text] [Related]
12. Towards personalized medicine: a scoping review of immunotherapy in sepsis.
Slim MA; van Mourik N; Bakkerus L; Fuller K; Acharya L; Giannidis T; Dionne JC; Oczkowski SJW; Netea MG; Pickkers P; Giamarellos-Bourboulis EJ; Müller MCA; van der Poll T; Wiersinga WJ; ; Vlaar APJ; van Vught LA
Crit Care; 2024 May; 28(1):183. PubMed ID: 38807151
[TBL] [Abstract][Full Text] [Related]
13. Advances in the Study of Immunosuppressive Mechanisms in Sepsis.
Fu X; Liu Z; Wang Y
J Inflamm Res; 2023; 16():3967-3981. PubMed ID: 37706064
[TBL] [Abstract][Full Text] [Related]
14. Targeting macrophage immunometabolism: Dawn in the darkness of sepsis.
Kumar V
Int Immunopharmacol; 2018 May; 58():173-185. PubMed ID: 29625385
[TBL] [Abstract][Full Text] [Related]
15. Monitoring immunomodulation in patients with sepsis.
Kyriazopoulou E; Giamarellos-Bourboulis EJ
Expert Rev Mol Diagn; 2021 Jan; 21(1):17-29. PubMed ID: 33183116
[No Abstract] [Full Text] [Related]
16. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.
Hotchkiss RS; Monneret G; Payen D
Nat Rev Immunol; 2013 Dec; 13(12):862-74. PubMed ID: 24232462
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy in the context of sepsis-induced immunological dysregulation.
Wu Y; Wang L; Li Y; Cao Y; Wang M; Deng Z; Kang H
Front Immunol; 2024; 15():1391395. PubMed ID: 38835773
[TBL] [Abstract][Full Text] [Related]
18. Emerging therapies for sepsis and septic shock.
Oh HM
Ann Acad Med Singap; 1998 Sep; 27(5):738-43. PubMed ID: 9919353
[TBL] [Abstract][Full Text] [Related]
19. How could we enhance translation of sepsis immunology to inform immunomodulation trials in sepsis?
Shankar-Hari M
Crit Care; 2017 May; 21(1):125. PubMed ID: 28571579
[TBL] [Abstract][Full Text] [Related]
20. [Advances in sepsis induced immunosuppression and immunomodulation therapy].
He X; Bo L; Jiang C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Dec; 30(12):1202-1205. PubMed ID: 30592959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
